Chong Kun Dang Pharmaceutical Corp.
185750.KS
₩64,900
Updated: 24/09/2026, 05:14:17
Market Cap
₩855.13B
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
KR
Stock valuation chart
One-year closing share-price history for 185750.KS
Company Profile
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetics, antiviruses, beta-blockers, anti-hyperlipidemia, and others. The company was founded on May 7, 1941 and is headquartered in Seoul, South Korea.
KRW
KSC
CEO: Young-Ju Kim
Employees: 2,304
Asset Summaries
Latest generated summaries for 185750.KS
No summaries found.
Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for 185750.KS.
- Share price
- ₩64,900
- Market cap
- ₩855.13B
- Exchange
- KSC
- Currency
- KRW
- CEO
- Young-Ju Kim
- Employees
- 2,304
- IPO date
- 06/12/2013
- Beta
- -0.434
- Last dividend
- ₩0
- Day range
- ₩64,000 – ₩65,400
- 52-week range
- ₩63,000 – ₩98,100
- 1-day performance
- 0.46%
- 1-year performance
- 3.02%
- Current drawdown (1Y)
- -33.84%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- KR7185750007
- Created
- 07/09/2026, 05:15:49
- Last update
- 24/09/2026, 05:14:17
Track Chong Kun Dang Pharmaceutical Corp. with an AI analyst
See which prediction-market events move 185750.KS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Latest Database News
News linked to 185750.KS from your Railway `news_articles` table.
No news found for this symbol.